+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 44 Pages
  • April 2024
  • GlobalData
  • ID: 1495422
Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genedrive Plc (Genedrive) formerly Epistem Holdings Plc specializes in the development of point-of-care molecular diagnostic platforms. The company's major activities include the creation of innovative tests for various clinical indications such as genotyping, pathogen detection, and infectious disease detection. The company's major products include the Genedrive MT-RNR1 ID kit, used for detecting antibiotic-induced hearing loss in neonates, and the Genedrive CYP2C19 ID kit, a rapid point-of-care test for CYP2C19 genotyping. The company's products are primarily used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. The company provides its products in North America, Asia Pacific, Europe, Middle East and Africa (EMEA) region through its distribution partners. Genedrive is headquartered in Manchester, the UK.

Genedrive Plc Key Recent Developments

  • Apr 24, 2024: Genedrive PLC Clinical Trial Agreement
  • Mar 28, 2024: Genedrive Announces Interim results to 31 December 2023
  • Mar 15, 2024: Genedrive : Receipt of R&D Tax Credit Notice of Interim Results
  • Dec 06, 2023: Genedrive PLC Posting of annual report and notice of AGM

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Genedrive Plc - Key Facts
  • Genedrive Plc - Key Employees
  • Genedrive Plc - Key Employee Biographies
  • Genedrive Plc - Major Products and Services
  • Genedrive Plc - History
  • Genedrive Plc - Company Statement
  • Genedrive Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Genedrive Plc - Business Description
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: The UK
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Genedrive Plc - Corporate Strategy
  • Genedrive Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Genedrive Plc - Strengths
  • Genedrive Plc - Weaknesses
  • Genedrive Plc - Opportunities
  • Genedrive Plc - Threats
  • Genedrive Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Genedrive Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Genedrive Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Genedrive Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 24, 2024: Genedrive PLC Clinical Trial Agreement
  • Mar 28, 2024: Genedrive Announces Interim results to 31 December 2023
  • Mar 15, 2024: Genedrive : Receipt of R&D Tax Credit Notice of Interim Results
  • Dec 06, 2023: Genedrive PLC Posting of annual report and notice of AGM
  • Sep 11, 2023: Genedrive : Board changes
  • Mar 31, 2023: Genedrive PLC Half-year Report
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Genedrive Plc, Key Facts
  • Genedrive Plc, Key Employees
  • Genedrive Plc, Key Employee Biographies
  • Genedrive Plc, Major Products and Services
  • Genedrive Plc, History
  • Genedrive Plc, Subsidiaries
  • Genedrive Plc, Key Competitors
  • Genedrive Plc, Ratios based on current share price
  • Genedrive Plc, Annual Ratios
  • Genedrive Plc, Annual Ratios (Cont...1)
  • Genedrive Plc, Interim Ratios
  • Genedrive Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Genedrive Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Genedrive Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Genedrive Plc, Performance Chart (2019 - 2023)
  • Genedrive Plc, Ratio Charts
  • Genedrive Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Genedrive Plc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GenMark Diagnostics Inc
  • Yourgene Health Plc
  • Tiziana Life Sciences Plc
  • Immunodiagnostic Systems Holdings Ltd
  • GSK plc